Key facts
- EvidenceCare’s last known valuation is $77.4M (Mar 2025).
- It has raised $56.8M across 3 recorded rounds; the latest was Early Stage VC ($9.6M) in Mar 2025.
- Notable investors include Service Provider Capital, Keiretsu Forum, Texas Medical Center, Cultivation Capital, Tectonic Ventures — 12 tracked in total.
- EvidenceCare has filed 4 Form Ds with the SEC since 2020, most recently Mar 2025 ($9.6M sold to 66 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for EvidenceCare
Funding rounds
3 roundsAbout EvidenceCare
Developer of a clinical decision support platform intended to integrate seamlessly into a clinician's electronic health record workflow, delivering customized, interactive, and evidence-based guidance directly into the care process. The company's platform enhances clinical decision-making through sophisticated clinical decision support system technology, enabling healthcare providers to improve quality and safety, minimize liability, and increase operational efficiency while optimizing compliance with government-mandated quality programs.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2014
- Employees
- 45
- Website
- evidence.care/
- Ownership
- Privately Held (backing)
EvidenceCare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EvidenceCare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EvidenceCare in its N-PORT filings yet. We sweep new filings monthly.